We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

103 hedge funds and large institutions have $87.5M invested in Sanofi Contingent Value Rights in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

8% more capital invested

Capital invested by funds: $80.8M → $87.5M (+$6.65M)

1% less funds holding

Funds holding: 104 → 103 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

Holders
103
Holders Change
-1
Holders Change %
-0.96%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
9
Increased
11
Reduced
16
Closed
10
Calls
$17M
Puts
–
Net Calls
+$17M
Net Calls Change
+$1.83M

Top Buyers

Rank Fund Capital Flow
1
JCI
Jet Capital Investors
New York
+$997K
2
SCM
Stonehill Capital Management
New York
+$243K
3
BHMP
Bardin Hill Management Partners
New York
+$74.8K
4
HCM
Highbridge Capital Management
New York
+$16.9K
5
Goldman Sachs
Goldman Sachs
New York
+$9.35K

Top Sellers

Rank Fund Capital Flow
1
DAM
DLD Asset Management
New York
-$335K
2
CL
CSS LLC
Illinois
-$154K
3
Citadel Advisors
Citadel Advisors
Florida
-$70K
4
TL
TowerView LLC
New York
-$56.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$55K
Name Holding Trade Value Shares
Change 		Change in
Stake
WEC
51
Winslow Evans & Crocker
Massachusetts
$4K – – –
BNP Paribas Financial Markets
52
BNP Paribas Financial Markets
France
$3.06K – – –
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$2K -$40 -75 -2%
AG
54
Advisor Group
Arizona
$2K +$1 +2 +0%
LTFS
55
Ladenburg Thalmann Financial Services
Florida
$1K – – –
MCM
56
Manchester Capital Management
Vermont
$1K – – –
SIM
57
Sonora Investment Management
Arizona
$1K – – –
TFO
58
Tarbox Family Office
California
$1K – – –
EWM
59
Edge Wealth Management
New York
$1K +$18 +34 New
US Bancorp
60
US Bancorp
Minnesota
$1K +$86 +160 +12%
RMC
61
Resources Management Corp
Connecticut
$1K +$718 +1,335 New
SRC
62
Shufro Rose & Co
New York
$1K +$1.01K +1,872 New
SAM
63
Silverback Asset Management
North Carolina
$442 – – –
EW
64
Evoke Wealth
California
$132 +$127 +237 New
RE
65
RBC Europe
United Kingdom
$73 – – –
BCWM
66
Bartlett & Co Wealth Management
Ohio
$56 – – –
KFS
67
Kelly Financial Services
Massachusetts
$42 +$13 +25 +50%
ECM
68
Estabrook Capital Management
New York
$8 – – –
DAM
69
DLD Asset Management
New York
– -$335K -644,000 Closed
Citadel Advisors
70
Citadel Advisors
Florida
– -$70K -134,965 Closed
WVP
71
Worth Venture Partners
New Jersey
– -$15K -28,979 Closed
SDWMA
72
Schneider Downs Wealth Management Advisors
Pennsylvania
– -$13K -25,000 Closed
TSS
73
Two Sigma Securities
New York
– -$8K -15,918 Closed
ACA
74
Atlas Capital Advisors
Wyoming
– -$145 -280 Closed
First Manhattan
75
First Manhattan
New York
– -$50 -93 -66%
1 2
3
4

GCVRZ Hedge Fund Activity: Q3 2019 in Review

103 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2019, worth a combined $87.5M — up 8.2% from $80.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GCVRZ and 9 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 11 added.

The largest buyer was Jet Capital Investors, adding an estimated $997K. The largest seller was DLD Asset Management, exiting entirely with an estimated $335K sold.

  • 103 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2019, down from 104 in Q2 2019.
  • Funds reported $87.5M of Sanofi Contingent Value Rights stock for Q3 2019, up 8.2% quarter-over-quarter.
  • 9 funds opened new Sanofi Contingent Value Rights positions in Q3 2019 and 10 closed out, a net change of -1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2019 was Jet Capital Investors, an estimated $997K added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2019 was DLD Asset Management, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2019.